Old Web
English
Sign In
Acemap
>
Paper
>
SAT-398 LOW DOSE OF RITUXIMAB IS CLINICALLY AND COST EFFECTIVE IN PRIMARY MEMBRANOUS NEPHROPATHY
SAT-398 LOW DOSE OF RITUXIMAB IS CLINICALLY AND COST EFFECTIVE IN PRIMARY MEMBRANOUS NEPHROPATHY
2020
J. George
S. Alex
R Raji
M. George
A Gopal
A. Thomas
Noble Gracious
Keywords:
Membranous nephropathy
Urology
Rituximab
Medicine
low dose
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]